CHING-LEE FUKUDA is the head of Sidley’s IP Litigation practice in New York and a member of the firm’s Global Life Sciences Leadership Council. She is a reputable trial lawyer who was shortlisted in recent years for “Practitioner of the Year (Litigation) – New York” by Managing IP and “Patent Lawyer of the Year” by IFLR in its Women in Business Law Awards. For two years in a row, she was awarded “Post-Grant Proceedings Attorney of the Year” by LMG Life Sciences for her work on behalf of medtech, medical devices, and chemical companies. Clients describe her as having “superb legal acumen,” “a great intellect,” that she “can handle the most complex of cases,” and that “Ching-Lee tells you what you need to hear, not just what you want to hear, and for that reason is someone you can trust, which is critical in big-ticket patent litigation.”

With 25 years of experience, Ching-Lee has led significant IP litigation victories in federal courts, at the ITC, the PTAB, and the Federal Circuit, focusing on electronics, software, medtech, medical devices, and chemicals. Her successes include numerous jury and bench trial wins, as well as wins during preliminary injunction, at summary judgment, and on appeal. She also has led and/or participated in about 100 PTAB proceedings on behalf of petitioners and patent owners. Over the past several years, four of her cases have been awarded “Impact Case of the Year” by LMG Life Sciences.


Ching-Lee is a regular speaker at conferences and seminars and is widely quoted and published in media, particularly regarding §101 patent eligibility, PTAB proceedings, jury trials, and DEI issues. She is a Member of Law360’s 2022 Intellectual Property Editorial Advisory Board, and a Co-Chair of the IP Programming Subcommittee for NAPABA.